Leptospirosis Workup
- Author: Sandra G Gompf, MD, FACP, FIDSA; Chief Editor: Burke A Cunha, MD more...
Laboratory Studies
Laboratory studies are used for two purposes—to confirm the diagnosis and to determine the extent of organ involvement and severity of complications. Laboratory confirmation of leptospirosis can be accomplished in 2 different ways.
Isolation of the leptospires from human tissue or body fluids is the criterion standard. Urine is the most reliable body fluid to study because the urine contains leptospires from the onset of clinical symptoms until the third week of infection. Other body fluids (eg, blood, cerebrospinal fluid [CSF]) contain the organism, but the window of opportunity to isolate them is shorter.
Tissues (ie, liver, muscle, kidney, skin, eyes) are also sources of identification of the leptospires but are obviously more complicated to acquire. Isolation of leptospires can be difficult and time consuming, involving reference laboratories and often taking several months to complete.
More often, paired acute and convalescent serum specimens are used to confirm the diagnosis. Again, this is a delayed means of confirmation because the acute sera are collected 1-2 weeks after onset of symptoms, and the convalescent sera are collected 2 weeks afterward. Antileptospire antibodies in these samples are detected using the microscopic agglutination test (MAT). The Centers for Disease Control and Prevention (CDC) laboratory in Atlanta, Georgia, performs the MAT using 23 leptospire antigens. A 4-fold rise in MAT titer between acute and convalescent sera with any of these antigens confirms the diagnosis of leptospirosis.
See the image below.
Darkfield microscopy of leptospiral microscopic agglutination test. (This image is in the public domain and thus free of any copyright restrictions. Courtesy of the Centers for Disease Control/Mrs. M. Gatton) Faster laboratory methods may strongly suggest the diagnosis of leptospirosis, but they may be no more readily available than the CDC laboratory in Atlanta. A single MAT titer of 1:800 on any sera or identification of spirochetes on dark-field microscopy, when accompanied by the appropriate clinical scenario, is strongly suggestive.
In suspected leptospirosis, further laboratory studies should be routinely performed to determine the extent and severity of organ involvement after the acute phase of illness. A CBC count is necessary.
See the image below.
A scanning electron micrograph depicting Leptospira atop a 0.1-µm polycarbonate filter. (This image is in the public domain and thus free of any copyright restrictions. Courtesy of the Centers for Disease Control/Rob Weyant) Significant anemia due to pulmonary and gastrointestinal hemorrhage can occur. The platelet count may be diminished as a component of DIC.
Levels of blood urea nitrogen and serum creatinine may be profoundly elevated in the anuric or oliguric phase. Tubulointerstitial nephritis is the main cause of acute renal injury in Weil disease. In addition, renal magnesium and potassium wasting is common in persons with leptospirosis.[11]
Serum bilirubin levels elevate as part of the obstructive disease due to capillaritis in the liver. Levels of hepatocellular transaminases are elevated less often and less significantly (usually < 200 U/L). Jaundice and bilirubinemia disproportional to hepatocellular damage is common in leptospirosis; alkaline phosphatase levels may be elevated 10-fold.
Coagulation times may be elevated in patients with hepatic dysfunction and/or DIC.
Serum creatine kinase levels (MM fraction) are often elevated in patients with muscular involvement.
Analysis of the CSF is useful only in excluding other causes of bacterial meningitis. Leptospires is routinely isolated from the CSF, but this finding does not change management of the disease.
Imaging Studies
Imaging studies are also useful in determining the extent and severity of organ involvement.
The most common abnormality on chest radiography is bilateral diffuse airspace disease. Chest radiography may also reveal cardiomegaly and pulmonary edema due to myocarditis. In patients with alveolar hemorrhage due to pulmonary capillaritis, the lung parenchyma may contain multiple patchy infiltrates.
Biliary tract ultrasonography can reveal an acalculous cholecystitis.
Histologic Findings
Shortly after inoculation and during the incubation period, leptospires are actively replicating in the liver. The leptospires then disseminate throughout the body and infect multiple tissues.
Silver staining and immunofluorescence are used to identify leptospires in the liver, spleen, kidney, CNS, muscles, and heart. During this acute phase, histology reveals these organisms without much inflammatory infiltrate. In addition to the finding of leptospires during histologic examination, the pathologic effects of leptospiral toxins are also apparent. See the image below.
Silver stain, liver, fatal human leptospirosis. (This image is in the public domain and thus free of any copyright restrictions. Courtesy of the Centers for Disease Control/Dr. Martin Hicklin) Leptospirosis may be seen as an infective systemic vasculitis.[12] Leptospiral toxins break down endothelial cell membranes of capillaries. This toxin-mediated process allows for extravasation of blood and leptospires from blood vessels into the supported parenchyma. Secondarily, because the capillaries are no longer functional, ischemia and cell death can occur. Later in infection, mononuclear cells predominate in the areas of this focal cell necrosis.
Leptospires can be identified in immunologically privileged sites, such as renal tubules, CNS, and the anterior chamber of the eyes, for weeks to months after the initial infection. In nonhuman animals, the intended hosts of infection, the leptospires establish residence in these immunologically privileged sites. Provided that the animal survives the initial infection, a chronic carrier state is then established, and histology reveals leptospires at these sites for years after initial infection.
Yang CW. Leptospirosis in Taiwan--an underestimated infectious disease. Chang Gung Med J. Mar-Apr 2007;30(2):109-15. [Medline].
Chierakul W, Tientadakul P, Suputtamongkol Y, et al. Activation of the coagulation cascade in patients with leptospirosis. Clin Infect Dis. Jan 15 2008;46(2):254-60. [Medline].
Wagenaar JF, Goris MG, Sakundarno MS, et al. What role do coagulation disorders play in the pathogenesis of leptospirosis?. Trop Med Int Health. Jan 2007;12(1):111-22. [Medline].
Katz AR, Buchholz AE, Hinson K, Park SY, Effler PV. Leptospirosis in hawaii, USA, 1999-2008. Emerg Infect Dis. Feb 2011;17(2):221-6. [Medline].
Gaspari R, Annetta MG, Cavaliere F, et al. Unusual presentation of leptospirosis in the late stage of pregnancy. Minerva Anestesiol. Jul-Aug 2007;73(7-8):429-32. [Medline].
Khosravi M, Bastani B. Acute renal failure due to leptospirosis in a renal transplant recipient: a brief review of the literature. Transplant Proc. May 2007;39(4):1263-6. [Medline].
Pappachan JM, Mathew S, Thomas B, et al. The incidence and clinical characteristics of the immune phase eye disease in treated cases of human leptospirosis. Indian J Med Sci. Aug 2007;61(8):441-7. [Medline].
Dolhnikoff M, Mauad T, Bethlem EP, et al. Pathology and pathophysiology of pulmonary manifestations in leptospirosis. Braz J Infect Dis. Feb 2007;11(1):142-8. [Medline].
Dall'Antonia M, Sluga G, Whitfield S, et al. Leptospirosis pulmonary haemorrhage: a diagnostic challenge. Emerg Med J. Jan 2008;25(1):51-2. [Medline].
Spichler A, Spichler E, Moock M, et al. Acute pancreatitis in fatal anicteric leptospirosis. Am J Trop Med Hyg. May 2007;76(5):886-7. [Medline].
Khositseth S, Sudjaritjan N, Tananchai P, et al. Renal magnesium wasting and tubular dysfunction in leptospirosis. Nephrol Dial Transplant. Mar 2008;23(3):952-8. [Medline].
Chakurkar G, Vaideeswar P, Pandit SP, et al. Cardiovascular lesions in leptospirosis: an autopsy study. J Infect. Mar 2008;56(3):197-203. [Medline].
Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev. Feb 15 2012;2:CD008264. [Medline].
Dursun B, Bostan F, Artac M, et al. Severe pulmonary haemorrhage accompanying hepatorenal failure in fulminant leptospirosis. Int J Clin Pract. Jan 2007;61(1):164-7. [Medline].
Shenoy VV, Nagar VS, Chowdhury AA, Bhalgat PS, Juvale NI. Pulmonary leptospirosis: an excellent response to bolus methylprednisolone. Postgrad Med J. Sep 2006;82(971):602-6. [Medline]. [Full Text].
Meaudre E, Asencio Y, Montcriol A, et al. [Immunomodulation in severe leptospirosis with multiple organ failure: plasma exchange, intravenous immunoglobulin or corticosteroids?]. Ann Fr Anesth Reanim. Feb 2008;27(2):172-6. [Medline].
Wang Z, Jin L, Wegrzyn A. Leptospirosis vaccines. Microb Cell Fact. Dec 11 2007;6:39. [Medline]. [Full Text].
Boyer AS, Runyan RB. TGFbeta Type III and TGFbeta Type II receptors have distinct activities during epithelial-mesenchymal cell transformation in the embryonic heart. Dev Dyn. Aug 2001;221(4):454-9. [Medline].
Centers for Disease Control and Prevention. Brief report: Leptospirosis after flooding of a university campus--Hawaii, 2004. MMWR Morb Mortal Wkly Rep. Feb 10 2006;55(5):125-7. [Medline]. [Full Text].
Centers for Disease Control and Prevention. Outbreak of leptospirosis among white-water rafters--Costa Rica, 1996. MMWR Morb Mortal Wkly Rep. Jun 27 1997;46(25):577-9. [Medline]. [Full Text].
Cox TE, Smythe LD, Leung LK. Flying foxes as carriers of pathogenic Leptospira species. J Wildl Dis. Oct 2005;41(4):753-7. [Medline].
Dall'Antonia M, Sluga G, Whitfield S, et al. Leptospirosis pulmonary haemorrhage: a diagnostic challenge. Emerg Med J. Jan 2008;25(1):51-2. [Medline].
Doudier B, Garcia S, Quennee V, et al. Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect. Apr 2006;12(4):299-300. [Medline].
Faine S. Leptospira and Leptospirosis. Boca Raton: CRC Press Inc; 1994.
Farr RW. Leptospirosis. Clin Infect Dis. Jul 1995;21(1):1-6; quiz 7-8. [Medline].
Masuzawa T, Okamoto Y, Une Y, et al. Leptospirosis in squirrels imported from United States to Japan. Emerg Infect Dis. Jul 2006;12(7):1153-5. [Medline]. [Full Text].
Moore GE, Guptill LF, Glickman NW, et al. Canine leptospirosis, United States, 2002-2004. Emerg Infect Dis. Mar 2006;12(3):501-3. [Medline].
O'Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis. Jul-Aug 1991;13(4):705-9. [Medline].
Sanford JP. Leptospirosis. In: Harrison's Principles of Internal Medicine. 13th ed. New York, NY: McGraw-Hill, Inc; 740-3.
Sejvar J, Bancroft E, Winthrop K, et al. Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000. Emerg Infect Dis. Jun 2003;9(6):702-7. [Medline]. [Full Text].
Speelman P. Leptospirosis. In: Harrison's Principle of Internal Medicine. 14th ed. New York, NY: McGraw-Hill, Inc; 1036-38.
Tappero J, Ashford D, Perkins N. Leptospira species (Leptospirosis). In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. Philadelphia, Pa: Churchill Livingstone; 2000:2495-500.

